Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "australia"

PolicyRSSMay 13

Australia, New Zealand develop guidelines for SMA newborn screening

Australia and New Zealand have created new guidelines to help doctors identify and treat spinal muscular atrophy (SMA) in newborns as early as possible. These guidelines combine best practices for screening babies at birth, confirming the diagnosis, and starting treatment right away. This is important because early treatment can significantly improve outcomes for children with SMA.

WHY IT MATTERSIf you live in Australia or New Zealand with a newborn or are planning to have children, these new guidelines mean your baby is more likely to be screened for SMA at birth and treated immediately if affected, which can prevent severe muscle weakness.
Good to knowspinal muscular atrophy

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases